ADAM28 from both endothelium and gastric cancer cleaves von Willebrand Factor to eliminate von Willebrand Factor-induced apoptosis of gastric cancer cells.

MLA

Yin, Qianru, et al. “ADAM28 from Both Endothelium and Gastric Cancer Cleaves von Willebrand Factor to Eliminate von Willebrand Factor-Induced Apoptosis of Gastric Cancer Cells.” European Journal of Pharmacology, vol. 898, May 2021, p. 173994. EBSCOhost, https://doi.org/10.1016/j.ejphar.2021.173994.

APA

Yin, Q., Gu, J., Qi, Y., Lu, Y., Yang, L., Liu, J., & Liang, X. (2021). ADAM28 from both endothelium and gastric cancer cleaves von Willebrand Factor to eliminate von Willebrand Factor-induced apoptosis of gastric cancer cells. European Journal of Pharmacology, 898, 173994. https://doi.org/10.1016/j.ejphar.2021.173994

Chicago

Yin, Qianru, Jiayi Gu, Yingxue Qi, Yuxin Lu, Lanxin Yang, Jianwen Liu, and Xin Liang. 2021. “ADAM28 from Both Endothelium and Gastric Cancer Cleaves von Willebrand Factor to Eliminate von Willebrand Factor-Induced Apoptosis of Gastric Cancer Cells.” European Journal of Pharmacology 898 (May): 173994. doi:10.1016/j.ejphar.2021.173994.